EMN

Business Context and Reporting Period

Company: Eastman Chemical Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2007
Overview: Eastman operates five reportable segments: Coatings, Adhesives, Specialty Polymers and Inks (CASPI); Fibers; Performance Chemicals and Intermediates (PCI); Performance Polymers; and Specialty Plastics (SP). The quarter was characterized by strategic divestitures, including the agreement to sell the San Roque, Spain PET facility, and the impact of accelerated depreciation from planned shutdowns of older assets.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Sales remained flat year-over-year (-0.4%), driven by a 10% increase in continuing product lines offset by the absence of $228 million in sales from divested product lines in Q1 2006 and the inclusion of $70 million in contract ethylene sales.
• Profitability: Operating earnings declined 27% to $135 million. This decrease was primarily due to $21 million in asset impairments/restructuring charges and $14 million in accelerated depreciation. Excluding these items, adjusted operating earnings were $170 million, a decrease of 11% from the prior year.
• Cash Flow: Operating cash flow turned negative at ($66) million, compared to $37 million provided in Q1 2006. The primary driver was a $100 million contribution to U.S. defined benefit pension plans (compared to $20 million in Q1 2006) and lower net earnings.
• Segment Performance:
  • Performance Polymers: Reported an operating loss of $51 million, down from $17 million earnings, largely due to the divestiture of PE businesses and $21 million in impairment charges related to the Spain facility.
  • PCI: Operating earnings increased 32% to $54 million, driven by strong volume and price increases, though impacted by $7 million in accelerated depreciation.
  • CASPI & Fibers: CASPI earnings rose 18% to $65 million; Fibers earnings declined 11% to $59 million due to lower volume and higher raw material costs.

Guidance, Outlook, and Risks

• 2007 Outlook: Management expects strong volumes but continued volatility in raw material and energy costs. They anticipate approximately $50 million in accelerated depreciation for the full year due to the phase-out of older cracking units and higher-cost PET assets.
• Capital Allocation: Priorities include paying quarterly dividends, funding targeted growth initiatives (approx. $450 million capital expenditures for 2007), funding pension plans, and share repurchases. A new $300 million share repurchase authorization was approved in February 2007; $33 million was utilized in Q1.
• Strategic Actions: The company is aggressively restructuring the Performance Polymers segment, including the sale of the Spain facility (expected Q2 2007 completion) and debottlenecking the new IntegRex facility in South Carolina.
• Risks: Key risks include raw material availability and cost volatility, foreign currency exchange rate fluctuations, and the outcome of ongoing litigation (sorbates and asbestos), though management does not expect these to have a material adverse effect on overall financial condition.

Investor Verification Checklist

• Impairment Charges: Verify the $21 million charge related to the San Roque, Spain facility and the timeline for the sale completion.
• Pension Funding: Confirm the $100 million pension contribution was a one-time Q1 event and that no further contributions are planned for 2007.
• Accelerated Depreciation: Monitor the $50 million full-year estimate for accelerated depreciation and its impact on future earnings.
• Performance Polymers Turnaround: Assess the progress of the new IntegRex facility in South Carolina and the impact of the Spain divestiture on segment profitability.
• Raw Material Costs: Track the ability to pass through increased raw material and energy costs to customers to maintain gross margins.